China Healthcare Summit
November 2-3, 2023 | Shanghai

November 7-8, 2023 | Digital

BioCentury and BayHelix’s China Healthcare Summit marks its 10th Anniversary with a return to Shanghai, gathering C-level executives from Asia and beyond for renewed cross-border collaboration and discussion. Innovation from Asian biotechs is on the rise, presenting new opportunities for partnership and investment. China Summit is specifically tailored for C-level executives and VCs, with a strategic program offering a first-hand look at the innovation, business, and policy transformations taking place in China and Asia. Don’t miss this opportunity to join your peers in-person in Shanghai Nov. 2-3, and for an additional 2 days of virtual meetings from Nov. 7-8, to explore transformative opportunities with global reach.

---

Written by Richard Daverman, PhD. Click a link below to view the mailing archive as if it had been sent to you. 2012-04-27 01:30 Watson Pharma Buys Actavis in a Marriage of Generic Drugmakers and more... 2012-04-26 01:30 SK Pharm and Hanmi Pharm Will Bring Epilepsy Treatment to China 2012-04-25 01:30 Origin Agritech Sets Up Research Institute with Henan Agricultural University 2012-04-24 01:30 S*Bio Out-licenses Myelofibrosis Treatment to Cell Therapeutics 2012-04-22 01:30 The Week in Review: Fidelity Starts New VC Fund for China Healthcare 2012-04-21 01:30 Daiichi Sankyo Buys Shanghai Xinshengyuan Pharma 2012-04-20 01:30 TCM Treatment for Angina Approved for Use in Europe 2012-04-19 01:30 Luqa Pharma Out-licenses AfMET Rights for AntiFungal; Keeps China Rights 2012-04-18 01:30 Research Tool Maker Fluidigm Opens China Office 2012-04-17 01:30 Fidelity Targets Healthcare for Half of New $250 Million China Fund 2012-04-15 01:30 The Week in Review: Fosun Pharma Given OK for Hong Kong IPO 2012-04-14 01:30 China Cord Blood Announces $65 Million Investment from KKR 2012-04-13 01:30 ThermoGenesis Gains SFDA Approval for Stem Cell Processing Device 2012-04-12 01:30 Fosun Pharma Given OK for Hong Kong IPO and more... 2012-04-11 01:30 Lotus Pharma Runs Out of Cash and more... 2012-04-10 01:30 Hainan Haiyao Uses Knowshine to Develop Antibiotic Intermediate 2012-04-08 01:30 The Week in Review: Henan Taloph Pharma Raises $63 Million 2012-04-07 01:30 Zhejiang Hisun Pharma Files for US Approval to Start Clinical Trial of Statin 2012-04-06 01:30 Henan Taloph Raises $63.4 Million to Fund Projects 2012-04-05 01:30 Barclays Remains Negative on Most China Pharma Stocks Near-Term 2012-04-04 01:30 PhytoCeutica of the US to Advance Clinical Trials of TCM for Cancer 2012-04-03 01:30 Agenix to File for China Clinical Trials of Hepatitis Treatment 2012-04-01 01:30 The Week in Review: Huapont Pharma Raises $146 Million   << Archive Index • Subscribe >>   Subscription preference center Archive Powered by FeedBlitz Not a ChinaBio®Today Subscriber? Here's what you get with a paid subscription to ChinaBio® Today: Website access to all current articles and commentary Full access to over 2000 archived articles on the biotech industry Get started now for as little as $20... ChinaBio and ChinaBio Today are trademarks of ChinaBio LLC